FRI538 Discovery And Characterization Of Orally Bioavailable Nonpeptide Thyroid Stimulating Hormone Receptor (TSHR) Antagonists For The Treatment Of Graves’ Disease

Disclosure: M.A. Fowler: Employee; Self; Crinetics Pharmaceuticals. Stock Owner; Self; Crinetics Pharmaceuticals. C. Regan: Employee; Self; Crinetics Pharmaceuticals. Stock Owner; Self; Crinetics Pharmaceuticals. J. Zhao: Employee; Self; Crinetics Pharmaceuticals. Stock Owner; Self; Crinetics Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowler, Melissa A, Regan, Collin, Zhao, Jian, Coutinho, Eulalia, Fleck, Beth, Castellanos, Anel A, Muller, Eric, Johns, Michael, Tang, Yang, Sturchler, Emmanuel, Chen, Mi, Retting, Kelsey, Dalvie, Deepak, Betz, Stephen F, Markison, Stacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555201/
http://dx.doi.org/10.1210/jendso/bvad114.1883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555201/
http://dx.doi.org/10.1210/jendso/bvad114.1883

Ejemplares similares